X0306 4 2018-06-01 0 0001308547 Dolby Laboratories, Inc. DLB 0001200469 YEAMAN KEVIN J C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET SAN FRANCISCO CA 94103 1 1 0 0 President and CEO Performance-Based Stock Option (Right to Buy) 45.50 2018-06-01 5 G 0 E 97199 0.00 D 2023-12-15 Class A Common Stock 97199 0 D Performance-Based Stock Option (Right to Buy) 45.50 2018-06-01 5 G 0 E 97199 0.00 A 2023-12-15 Class A Common Stock 97199 97199 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Employee Stock Option (Right to Buy) 45.50 2018-06-01 5 G 0 E 194399 0.00 D 2026-12-15 Class A Common Stock 194399 0 D Employee Stock Option (Right to Buy) 45.50 2018-06-01 5 G 0 E 194399 0.00 A 2026-12-15 Class A Common Stock 194399 194399 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Performance-Based Stock Option (Right to Buy) 62.32 2018-06-01 5 G 0 E 90000 0.00 D 2024-12-15 Class A Common Stock 90000 0 D Performance-Based Stock Option (Right to Buy) 62.32 2018-06-01 5 G 0 E 90000 0.00 A 2024-12-15 Class A Common Stock 90000 90000 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Employee Stock Option (Right to Buy) 62.32 2018-06-01 5 G 0 E 180000 0.00 D 2027-12-15 Class A Common Stock 180000 0 D Employee Stock Option (Right to Buy) 62.32 2018-06-01 5 G 0 E 180000 0.00 A 2027-12-15 Class A Common Stock 180000 180000 I By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 Effective June 1, 2018 the Reporting Person transferred this option as a gift to a revocable trust. The vesting of this performance-based stock option ("PSO") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2016 and ending December 15, 2019. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 125% of the target award amount based on total shareholder return at the end of the three-year performance period. The actual PSO award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. This option was granted for a total of 194,399 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2016, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. The vesting of this performance-based stock option ("PSO") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2017 and ending December 15, 2020. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 125% of the target award amount based on total shareholder return at the end of the three-year performance period. The actual PSO award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. This option was granted for a total of 180,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2017, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. /s/ Daniel Rodriguez, as Attorney-in-Fact for Kevin Yeaman 2018-06-01